Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders

April 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., April 6, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that its 2011 Annual Meeting of Stockholders will be held on June 2, 2011, at 10:00 a.m. local time at its offices located at 68 Elm Street, Hopkinton, Massachusetts.  The record date for...

Philips to Take Orders for the Ingenia MRI System in the United States

April 6, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass., April 6, 2011 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the United States availability of the Ingenia MRI system, the first-ever digital broadband magnetic resonance imaging (MRI) solution. Previously available in Europe, Canada and...

Cardica Receives Key Patent for Microcutterâ„¢ Surgical Cutting and Stapling Device

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., April 6, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that the U.S. Patent and Trademark Office (USPTO) has issued the company Patent No. 7,918,376 for its proprietary Microcutter™ technology. This patent relates to the articulation of a surgical...

Advertisement

Aethlon Medical Releases Shareholder Letter

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce has issued the following letter to shareholders. (Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) To our Shareholders: On April 1st, we...

CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- CareFusion (NYSE: CFN ), a leading global medical technology company, today announced it has acquired technology to automate the segregation of pharmaceutical waste, helping hospitals reduce cost, improve regulatory controls and facilitate environmental...

e-MDs Selected by Medical Society of the State of New York

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, April 6, 2011 /- e-MDs, a leading provider of electronic health records (EHRs), announced they have been selected as an EHR vendor partner by the Medical Society of the State of New York (MSSNY).  MSSNY is a non-profit organization committed to representing the medical...

Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste

April 6, 2011 5:37 am | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., April 6, 2011 /- Kimberly-Clark Health Care today announced achievements that highlight the company's substantial progress in its sustainability initiatives.  From rewarding customers for their sustainability efforts to developing recyclable uses for medical packaging...

MEDX Installs Two Next Generation T-Questâ„¢ Compact Gamma Cameras

April 6, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

ARLINGTON HEIGHTS, Ill., April 6, 2011 /PRNewswire/ -- MEDX, Inc., a leading provider of nuclear medicine equipment, today introduced the next generation T-Quest™ compact gamma camera.  The FDA-cleared T-Quest, includes enhanced thyroid imaging and now features expanded imaging...

Advertisement

Study Shows Positron Emission Mammography (PEM) is Easy for Breast Imagers to Learn Regardless of Experience

April 6, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, April 6, 2011 /- The American Journal of Roentgenology published original research from two separate studies this month demonstrating continued clinical acceptance of  the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner.  The first study...

REMINDER: PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Mobile Health Solution for Interested Licensees, Physicians, Patients, Payors and Investors

April 6, 2011 5:33 am | by PositiveID | News | Comments

REMINDER: PositiveID Corporation to Host WebEx of Its iglucose Diabetes Management Mobile Health Solution for Interested Licensees, Physicians, Patients, Payors and Investors

Strawberries May Slow Precancerous Growth in Esophagus

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Esophageal cancer is the third most common gastrointestinal cancer. • Six months of eating strawberry may decrease histological grade of precancerous lesions. • Strawberries may reduce cancer-related molecular events. ORLANDO, Fla. - Freeze-dried strawberries may be an alternative...

GOLFIG Increased Progression-free Survival in Colorectal Cancer Patients

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Duration of progression-free survival was 16.5 months with GOLFIG. • GOLFIG is safe and effective in patients with metastatic colorectal cancer. • Study prematurely terminated due to superior results of GOLFIG. ORLANDO, Fla. - Oncologists can use colorectal cancer patients' own...

Physical Health Scores Predict Breast Cancer Outcomes

April 6, 2011 5:32 am | by AACR | News | Comments

Tweet • Risk of recurrence increased in women with poor health scores. • Five percent improvement in physical health score can reduce risk. ORLANDO, Fla. - Breast cancer survivors with poor physical health scores had an elevated risk of poorer cancer outcomes, including recurrence and...

Advertisement

Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer

April 6, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., and OXFORD, England, April 6, 2011 /- BioWa, Inc. (BioWa) and Oxford BioTherapeutics Ltd (OBT) today announced that they have entered into a license agreement to provide OBT with access to BioWa's patented POTELLIGENT® Technology platform for the development of...

BioLife Solutions Announces Record Quarterly Revenue

April 6, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., April 6, 2011 /- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced preliminary revenue of $611,000 for its first quarter ended March 31, 2011. This represents...

IBM Helps Bring Smarter Healthcare to Nigeria's Cross River State

April 6, 2011 2:34 am | by IBM | News | Comments

Ahead of World Health Day, IBM (NYSE: IBM) announced details of its involvement with two government programs in Cross River State, Nigeria aimed at providing access to free healthcare and alleviating poverty. E-mail this page Save to del.icio.us Digg this

Bloxx Provides Peterborough & Stamford Hospitals NHS Foundation Trust with Cost-Effective and Superior Web Filtering

April 6, 2011 1:34 am | by RealWire | News | Comments

Increased levels of user and network protection with lower total cost of ownership, simplified on-going management and reduced risk and liability delivered by real-time Web filteringBloxx, the innovator in Web and Email content filtering, today announced that Peterborough & Stamford...

Jennerex and Transgene Announce Presentation of Phase 1 Data Demonstrating that JX-594 Administration Targets Tumor Vasculature

April 5, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO and ILLKIRCH, France, April 6, 2011 /- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene (NYSE Euronext Paris: FR0005175080), a...

Using MRI, researchers may predict which adults will develop Alzheimer's

April 5, 2011 9:32 pm | by EurekAlert | News | Comments

(Radiological Society of North America) Using MRI, researchers may be able to predict which adults with mild cognitive impairment are more likely to progress to Alzheimer's disease, according to the results of a new study.

Study: Socioeconomics playing reduced role in autism diagnoses

April 5, 2011 9:32 pm | by EurekAlert | News | Comments

(American Sociological Association) While there is an increasing equality in terms of the likelihood that children from communities and families across the socioeconomic spectrum will be diagnosed with autism, a new study finds that such factors still influence the chance of an autism...

New Neurons Help Brains Discriminate

April 5, 2011 8:35 pm | by Massachusetts Institute of Technology | News | Comments

A study shows that boosting new neurons helps mice differentiate between harmful and safe experiences.

CVS Caremark Named One of America's Most Reputable Companies by Reputation Institute

April 5, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., April 5, 2011 /- CVS Caremark has been named as one of the most reputable companies in the United States, according to the 2011 Most Reputable Companies list published today by Forbes magazine in partnership with the Reputation Institute. (Logo:...

Express Scripts Injects $226 Million Into Arizona Economy, Study Finds

April 5, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

PHOENIX, April 5, 2011 /- Express Scripts contributed more than $226 million to Arizona's economy in 2010, according to an economic analysis of the company's data by a university professor. (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) The economic impact study,...

New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix® (clopidogrel bisulfate)

April 5, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

NEW ORLEANS, April 5, 2011 /- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in...

NeuroVasx Receives FDA Approval for cPAX Aneurysm Treatment System

April 5, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., April 5, 2011 /- NeuroVasx announced today that the FDA has approved the cPAX Aneurysm Treatment System as a Humanitarian Use Device (HDE) for the treatment of large, giant and wide-neck cerebral aneurysms, which are typically the most difficult to treat.  The HDE...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading